ADMA Biologics, Inc.
€6.993
EUR
Last updated on --.
24h volume29.00
24h highest7.0575 EUR
24h lowest7.0008 EUR
24h Price movement-0.12%
ADMA recent prices
24 Hours
-0.12%-€0.008591
30 days
-25.53%-€2.397
60 days
-11.03%-€0.87628
90 days
-46.38%-€6.049
Key data
Previous close7.0017 EUR
Market cap1.70B EUR
Volume29.00
P/E ratio12.000000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.60996 EUR
Net income (FY)142.06M EUR
Revenue (FY)438.02M EUR
Last report dateMay 6, 2026
About ADMA Biologics, Inc.
HeadquartersRAMSEY
Employees (FY)647.00
Revenue per employee (FY)677.01K EUR
Net income per employee (FY)219.56K EUR
Listed onNasdaq
ADMA conversion tables
 |  |
|---|---|
| 0.5 ADMA | 3.496 EUR |
| 1 ADMA | 6.993 EUR |
| 5 ADMA | 34.96 EUR |
| 10 ADMA | 69.93 EUR |
| |
|---|---|
| 0.5 EUR | 0.071499 ADMA |
| 1 EUR | 0.143 ADMA |
| 5 EUR | 0.71499 ADMA |
| 10 EUR | 1.429 ADMA |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ADMA is trading at €6.993, -0.12% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ADMA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ADMA is currently trading at €6.993, -0.12% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ADMA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ADMA's P/E ratio is currently 12.000000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ADMA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ADMA's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
ADMA Biologics, Inc.'s market cap is currently 1.70B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume29.00
24h highest7.0575 EUR
24h lowest7.0008 EUR
24h Price movement-0.12%
Start trade with ADMA Perpetual
Sign up to trade